Clearance Summary
GEM Biover Microvascular Clamps received FDA 510(k) clearance under submission number K221843, sponsored by Synovis Micro Companies Alliance, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2022-09-14.
- Submission: K221843
- Applicant / Sponsor: Synovis Micro Companies Alliance, Inc.
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.4450
- Decision date: 2022-09-14
Classification & Regulation
This clearance is catalogued under FDA product code DXC and 21 CFR 870.4450, within the Cardiovascular review panel as a Class II device.